2,3-dihydro-1H-4-thia-1,5-diaza-anthraquinone | 121761-11-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2,3-dihydro-1H-4-thia-1,5-diaza-anthraquinone
• 英文别名: 2,3-dihydro-1H-[1,4]thiazino[3,2-g]quinoline-5,10-dione；2,3-Dihydro-1H-[1,4]thiazino[3,2-g]chinolin-5,10-dion；2,3-dihydro-1H-pyrido[3,2-g][1,4]benzothiazine-5,10-dione
• CAS: 121761-11-3
• 化学式: C₁₁H₈N₂O₂S
• 分子量: 232.263
• InChiKey: MCNJGFWFUYHFKH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  84.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  6,7-二氯-5,8-喹啉二酮 在 sodium sulfide 、 sodium hydroxide 作用下， 生成 2,3-dihydro-1H-4-thia-1,5-diaza-anthraquinone
  参考文献：
  名称：

  Schellhammer; Petersen, Justus Liebigs Annalen der Chemie, 1959, vol. 624, p. 108,114, 119

  摘要：

  DOI：

文献信息

• [EN] ANTI-INFLAMMATORY COMPOUNDS<br/>[FR] COMPOSES ANTI-INFLAMMATOIRES
  申请人：ITED NEW ZEALAND INST FOR CROP

  公开号：WO2006031134A1

  公开（公告）日：2006-03-23

  The invention relates to compounds of formula (I) or formula (II) which have anti-inflammatory activity and comprise a new class of NSAIDs. The compounds are therefore useful for treating inflammatory diseases or disorders. The invention also relates to pharmaceutical compositions containing these compounds, as well as methods of treating inflammatory diseases or disorders using compounds of formula (III) or formula (IV).

  本发明涉及式(I)或式(II)的化合物，具有抗炎活性，并包含一类新的非甾体抗炎药。因此，这些化合物可用于治疗炎症性疾病或疾患。本发明还涉及含有这些化合物的制药组合物，以及使用式(III)或式(IV)的化合物治疗炎症性疾病或疾患的方法。
• Anti-Inflammatory Compounds
  申请人：Denny Alexander William

  公开号：US20070265253A1

  公开（公告）日：2007-11-15

  The invention relates to compounds of formula (I) or formula (II) which have anti-inflammatory activity and comprise a new class of NSAIDs. The compounds are therefore useful for treating inflammatory diseases or disorders. The invention also relates to pharmaceutical compositions containing these compounds, as well as methods of treating inflammatory diseases or disorders using compounds of formula (III) or formula (IV).

  本发明涉及具有抗炎活性的式（I）或式（II）化合物，包括一种新的非甾体抗炎药类。因此，这些化合物可用于治疗炎症性疾病或疾病。本发明还涉及含有这些化合物的制药组合物，以及使用式（III）或式（IV）化合物治疗炎症性疾病或疾病的方法。
• The anti-cancer, anti-inflammatory and tuberculostatic activities of a series of 6,7-substituted-5,8-quinolinequinones
  作者：Benjamin J. Mulchin、Christopher G. Newton、James W. Baty、Carole H. Grasso、William John Martin、Michaela C. Walton、Emma M. Dangerfield、Catherine H. Plunkett、Michael V. Berridge、Jacquie L. Harper、Mattie S.M. Timmer、Bridget L. Stocker

  DOI：10.1016/j.bmc.2010.03.021

  日期：2010.5

  A variety of 6,7-substituted-5,8-quinolinequinones were synthesised and assessed for their anti-tumour and anti-inflammatory activities, and their ability to inhibit the growth of Mycobacterium bovis BCG. In particular, the introduction of a sulfur group at the 7-position of the quinolinequinone led to the discovery of two compounds, 6-methylamino-7-methylsulfanyl-5,8-quinolinequinone (10a) and 6-amino-7-methylsulfonyl-5,8-quinolinequinone ( 12), that exhibited selectivity for leukemic cells over T-cells, a highly desirable property for an anti-cancer drug. A number of anti-inflammatory ( AI) compounds were also identified, with 6,7-bis-methylsulfanyl-5,8-quinolinequinone (18a) exhibiting the highest AI activity (0.11 mu M), while 6,7-dichloro-5,8-quinolinequinone (7a), 6,7-dichloro-2-methyl-5,8-quinolinequinone (7b), and 6,7-bis-phenylsulfanyl-quinoline-5,8-diol ( 19) also exhibited good AI activity and specificity. Several quinolinequinone TB-drug candidates were identified. Of these, 6-amino-7-chloro-5,8-quinolinequinone ( 11) and 6-amino-7-methanesulfinyl-5,8-quinolinequinone ( 14), exhibited low MICs (1.56-3.13 mu g/mL) for the 100% growth inhibition of M. Bovis BCG. Some general trends pertaining to the functional group substitution of the quinolinequinone core and biological activity were also identified. (C) 2010 Elsevier Ltd. All rights reserved.
• ANTI-INFLAMMATORY COMPOUNDS
  申请人：NEW ZEALAND INSTITUTE FOR CROP & FOOD RESEARCH LIMITED

  公开号：EP1789422A1

  公开（公告）日：2007-05-30
• US7807668B2
  申请人：——

  公开号：US7807668B2

  公开（公告）日：2010-10-05